For years, obesity was often seen as a result of poor lifestyle choices. However, experts now suggest that biological factors ...

Experts are calling on the government to implement strategies that will better predict future Ozempic shortages.

CBS News Miami investigates the financial hurdles surrounding these medications and explores alternatives that may offer a ...

Regeneron reported Q4 2024 earnings today and declared its first-ever dividend of $0.88 per quarter. Click here to know what ...

However, patients will have to source their own syringes for the injections ... is in a head-to-head contest with the latter's Wegovy (semaglutide) brand. Both companies have been struggling ...

Danish pharmaceutical behemoth Novo Nordisk on Wednesday reported better-than-expected net profit in the fourth quarter, amid ...

Novo Nordisk's GLP-1 receptor agonist semaglutide has shown efficacy as a treatment for metabolic dysfunction-associated steatohepatitis (MASH) in a phase 3 trial, potentially teeing up US and ...

Victoza (liraglutide) and Ozempic (semaglutide) are two injectable drugs used to treat people with type 2 diabetes. The drugs, classified as GLP-1 agonists, have also been used for weight loss in ...